Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
UNCYthis companyUnicycive Therapeutics, Inc.	$3.68	-3.46×	3.04×	0×	-2.42×	-48.2%	0.0%	0.0%	0.0%	-87.9%	-97.1%	-34.2%	0.01×	1.12×	-415.73×	2.59×	0.0%	2	-0.44	2	C+
ACRVAcrivon Therapeutics, Inc. Common Stock	$1.64	-1.19×	0.82×	0×	-0.71×	-40.7%	0.0%	0.0%	0.0%	-69.2%	-73.0%	-70.4%	0.02×	0.51×	0×	7.69×	0.0%	1	-2.78	3	B-
BMEABiomea Fusion, Inc.	$0.60	-1.05×	2.19×	0×	-0.17×	48.4%	0.0%	0.0%	0.0%	-209.1%	-166.2%	-108.7%	0.05×	0.9×	0×	5.23×	0.0%	0	-18.95	2	C+
CAMPCAMP4 Therapeutics Corporation	$4.34	-2.31×	3.9×	53.24×	-1.56×	-1164.1%	53.1%	-1488.3%	-2298.5%	-168.5%	-50.8%	-16.0%	0.04×	2.13×	0×	7.35×	0.0%	1	-5.32	2	C
CBUSCibus, Inc.	$1.25	-0.63×	3.65×	21.88×	-3.72×	-625.8%	-62.8%	-1853.9%	-3492.3%	-582.2%	-23.2%	-64.3%	12.28×	-2.84×	-1.9×	0.72×	0.0%	3	-4.45	1	D+
HYFTMindWalk Holdings Corp.	$1.10	-5.39×	6.39×	4.89×	-5.11×	-295.2%	58.8%	-96.0%	-89.7%	-117.1%	-89.2%	-16.9%	0.3×	0.59×	0×	2.8×	0.0%	3	-9.88	1	D+
Peer median	—	-1.19×	3.65×	4.89×	-1.56×	-295.2%	0.0%	-96.0%	-89.7%	-168.5%	-73.0%	-64.3%	0.05×	0.59×	0×	5.23×	0.0%	1	-5.32	2	—